How Does Segmental Outflow Affect Outflow Resistance?
About the Research Project
Program
Award Type
Standard
Award Amount
$90,000
Active Dates
April 01, 2006 - March 31, 2009
Grant ID
G2006057
Acknowledgement
Goals
Glaucoma is a disease typically associated with elevated intraocular pressure (IOP) caused by increased resistance to aqueous humor outflow. Glaucoma is treated clinically by reducing IOP, but the precise factors responsible for controlling IOP and outflow resistance are not well understood.
Dr. Overby proposes to study how the hydrodynamic patterns of aqueous humor outflow change in response to stimuli that affect outflow resistance. His hypothesis is because aqueous humor is confined to flow through only a fraction of total area of outflow pathway, outflow resistance is correlated to the area that is actively involved in hydrodynamic filtration of aqueous humor.
Summary
To test this hypothesis, he will aim to develop a new tracer method that will combine with confocal microscopy to visualize the hydrodynamic patterns of outflow and measure the active area of aqueous humor filtration in human eyes. The second aim is to use this tracer technique to quantify the relationship between outflow resistance and filtration area for changing IOP that causes a change in outflow resistance. The long-term goal of this project is to translate this fundamental understanding of outflow hydrodynamics into a strategy to reduce outflow resistance and IOP in glaucomatous eyes.
Related Grants
National Glaucoma Research
Assessment of Vascular Resistance in Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Brad Fortune, OD, PhD
Current Organization
Legacy Devers Eye Institute
Assessment of Vascular Resistance in Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Brad Fortune, OD, PhD
Current Organization
Legacy Devers Eye Institute
National Glaucoma Research
Interleukin-10 As a Neuroprotective Factor in Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Tatjana Jakobs, MD
Current Organization
The Schepens Eye Research Institute, Mass. Eye and Ear
Interleukin-10 As a Neuroprotective Factor in Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Tatjana Jakobs, MD
Current Organization
The Schepens Eye Research Institute, Mass. Eye and Ear
National Glaucoma Research
From Resilience to Vulnerability: How Stress Accelerates Aging
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Dorota Skowronska-Krawczyk, PhD
Current Organization
University Of California, Irvine
From Resilience to Vulnerability: How Stress Accelerates Aging
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Dorota Skowronska-Krawczyk, PhD
Current Organization
University Of California, Irvine